US Antimony Corp Files 8-K on Material Agreement

TL;DR

US Antimony Corp filed an 8-K for a material agreement, details TBD.

AI Summary

United States Antimony Corporation filed an 8-K on October 7, 2025, reporting a material definitive agreement. The filing does not provide specific details on the agreement, its parties, or any associated dollar amounts or dates beyond the report date.

Why It Matters

This filing indicates a significant new development for United States Antimony Corporation, potentially impacting its business operations and financial standing.

Risk Assessment

Risk Level: medium — The filing indicates a material definitive agreement, which could be significant, but lacks specific details, creating uncertainty.

Key Players & Entities

• UNITED STATES ANTIMONY CORPORATION (company) — Registrant
• October 6, 2025 (date) — Earliest event reported
• October 7, 2025 (date) — Filing date
• Texas (jurisdiction) — State of incorporation
• 4438 W. Lovers Lane , Unit 100 , Dallas , TX 75209 (address) — Principal executive offices

FAQ

Key Financial Figures

• $0.01 — nge on which registered Common Stock, $0.01 par value UAMY NYSE American Commo
• $7.50 — "Common Stock"), at a purchase price of $7.50 per Share, for aggregate gross proceeds
• $26,250,000 — roceeds to the Company of approximately $26,250,000 (the "Offering"). The Offering is bein
• $25,558,750 — xpenses and the Credit will be equal to $25,558,750. The Offering is expected to close on o
• $65,000,000 — ng an aggregate offering price of up to $65,000,000 in the ATM Offering. Effective as of Oc
• $39,885,000 — ospectus Supplement from $65,000,000 to $39,885,000. As of October 6, 2025, after taking in
• $9,775,549 — ober 6, 2025, after taking into account $9,775,549 of shares of Common Stock that the Comp
• $30,109,451 — e Company may offer up to an additional $30,109,451 of shares of Common Stock (the "Current

Filing Documents

• uamy_8k.htm (8-K) — 29KB
• uamy_ex51.htm (EX-5.1) — 21KB
• uamy_ex101.htm (EX-10.1) — 172KB
• uamy_ex102.htm (EX-10.2) — 39KB
• uamy_ex51img3.jpg (GRAPHIC) — 3KB
• 0001654954-25-011525.txt ( ) — 441KB
• uamy-20251006.xsd (EX-101.SCH) — 5KB
• uamy-20251006_lab.xml (EX-101.LAB) — 14KB
• uamy-20251006_cal.xml (EX-101.CAL) — 1KB
• uamy-20251006_pre.xml (EX-101.PRE) — 9KB
• uamy-20251006_def.xml (EX-101.DEF) — 2KB
• uamy_8k_htm.xml (XML) — 4KB

01 Entry into a Material Definitive Agreement

Item 1.01 Entry into a Material Definitive Agreement On October 6, 2025, United States Antimony Corporation (NYSE: UAMY) (NYSE Texas: UAMY) ("USAC," "US Antimony," or the "Company") entered into a Securities Purchase Agreement (the "Purchase Agreement") with the institutional investor signatory thereto (the "Investor") pursuant to which the Company agreed to sell to the Investor, and the Investor agreed to purchase from the Company, in a registered direct offering, an aggregate of 3,500,000 shares (the "Shares") of the common stock, par value $0.01 per share, of the Company ("Common Stock"), at a purchase price of $7.50 per Share, for aggregate gross proceeds to the Company of approximately $26,250,000 (the "Offering"). The Offering is being made pursuant to the Company's effective shelf registration statement on Form S-3 (File No. 333-284057), which was originally filed with the Securities and Exchange Commission on December 27, 2024 and was declared effective on April 24, 2025. A.G.P./Alliance Global Partners (the "Placement Agent") acted as exclusive placement agent in connection with the Offering pursuant to a Placement Agency Agreement between the Company and the Placement Agent dated October 6, 2025 (the "Placement Agency Agreement"). The Placement Agency Agreement provides that the Placement Agent will receive a commission equal to 7% of the aggregate gross proceeds of the Offering minus a credit that will be applied to the Company on the Closing Date. Proceeds to the Company after expenses and the Credit will be equal to $25,558,750. The Offering is expected to close on or about October 7, 2025, subject to satisfaction of customary closing conditions (the "Closing Date"). A copy of each of the Purchase Agreement and the Placement Agency Agreement is attached hereto as Exhibit 10.1 and Exhibit 10.2, respectively, and is incorporated herein by reference. The Company is party to an Amended and Restated Sales Agreement, or "sales agreement," with the Place

01 Other Events

Item 8.01 Other Events. The information set forth in Item 1.01 above regarding the reduction of the ATM Prospectus Supplement is incorporated by reference herein in response to this Item.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 5.1 Opinion of Duane Morris LLP dated October 6, 2025 10.1 Securities Purchase Agreement dated as of October 6, 2025 between United States Antimony Corporation and the purchasers signatory thereto 10.2 Placement Agency Agreement dated as of October 6, 2025 between United States Antimony Corporation and A.G.P/Alliance Global Partners 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. UNITED STATES ANTIMONY CORPORATION Dated: October 6, 2025 By: /s/ Richard R. Isaak Richard R. Isaak SVP, Chief Financial Officer 3

View Full Filing

View this 8-K filing on SEC EDGAR